Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bempedoic acid in high CV risk hyperlipidemia
NCT02991118Phase 3Completed
- Sponsor
- Esperion Therapeutics
- Start
- Nov 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bempedoic acid in hypercholesterolemia, sponsored by Esperion Therapeutics. Started Nov 2016; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02991118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02991118.